By Wendy K. D. Selig, president and CEO of Melanoma Research Alliance
The Melanoma Research Alliance (MRA), a unique non-profit organization that funds the most promising melanoma research, was founded in 2007 by Debra and Leon Black under the auspices of the Milken Institute. In just six years, MRA has become the largest private funder of melanoma research and has awarded almost $48 million to 116 different research programs worldwide. MRA-supported projects are dedicated to accelerating progress toward the prevention, detection and treatment of deadly skin cancer.
In order to raise awareness of this disease and the need to invest in research for live-saving treatments, we are participating in Melanoma Awareness Month during the month of May. Investment in melanoma research is still sorely needed—the incidence of the disease is increasing across all segments of the population, including young adults and children. Melanoma is the most common cancer among men and women aged 25-29 and takes one life in the U.S. every hour.